News
Media
Conferences
CME/CE
Partners
Publications
Resources
Subscribe

Opinion|Videos|July 10, 2024

Factors Influencing Treatment Choice in Spasticity

Author(s)Khashayar Dashtipour, MD, PhD, Francois Bethoux, MD, Jennifer Smith, PA

A panel of experts discuss variation in spasticity between patients and the role disease severity can play.

Episodes in this series

Video 1 - 4 KOLs are feature in, "Definition and Pathophysiology of Spasticity"

EP. 1 Definition and Pathophysiology of Spasticity

Video 2 - 4 KOLs are feature in, "Changes in Presentation of Spasticity Over Time"

EP. 2 Changes in Presentation of Spasticity Over Time

4 KOLs are featured in this series.

EP. 3 Impact of Spasticity of Patient and Caregiver’s Quality of Life

4 KOLs are featured in this series.

EP. 4 Factors Influencing Treatment Choice in Spasticity

4 KOLs are featured in this series.

EP. 5 Treatment Options for Spasticity

4 KOLs are featured in this series.

EP. 6 Planning Spasticity Treatment Based on Patient Goals

4 KOLs are featured in this series.

EP. 7 Defining Severe Spasticity

4 KOLs are featured in this series.

EP. 8 Intrathecal Baclofen for Management of Severe Spasticity

4 KOLs are featured in this series.

EP. 9 Baclofen Pump for Treatment of Severe Spasticity

4 KOLs are featured in this series.

EP. 10 Managing Safety Concerns with ITB Pump

4 KOLs are featured in this series.

EP. 11 Ideal Candidates for ITB Pump

4 KOLs are featured in this series.

EP. 12 Long-term Data with ITB Pumps for Spasticity

A panel of 4 experts on spasticity

EP. 13 ITB Pump for Spasticity: Surveillance Registry Findings

A panel of 4 experts on spasticity

EP. 14 Practical Considerations when Using ITB Pump for Spasticity

A panel of 4 experts on spasticity

EP. 15 Potential for Use of ITB Pump Earlier in Spasticity

A panel of 4 experts on spasticity

EP. 16 Trends in Treatment of Spasticity

A panel of 4 experts on spasticity

EP. 17 Advice for Clinicians Treating Spasticity

Discuss the variation in spasticity presentation among patients and within the same patient.
1. How do you factor in this variability when recommending treatments?
What roles do disease severity, anatomical distribution, and comorbidities play in choosing among different options?
How important is it to understand triggers of spasticity or underlying disability causes when managing moderate/severe spasticity?

Newsletter

Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.

Related Content

NeurologyLive® Brain Games: November 16, 2025

ByMarco Meglio,Louie Pasculli

November 16th 2025

Carla Tortorella, MD, PhD

Cladribine More Effective Than S1P Receptor Modulators in Treating Relapsing-Remitting MS, Study Shows

ByLouie Pasculli

November 15th 2025

Elena Grebenciucova, MD, on Evolving Standards in NMOSD Diagnosis and Management

ByElena Grebenciucova, MD,Marco Meglio

November 15th 2025

BBP-418 Success in LGMD, Alixorexton Improves Narcolepsy Symptoms, Fenebrutinib Meets Phase 3 End Points

ByNeurologyLive® Staff

November 15th 2025

FDA Adds Boxed Warning, Narrows Indication for DMD Gene Therapy

ByIsabella Ciccone, MPH

November 14th 2025

Latest CME

Unlocking the Future of Glioma Care: Integrating Recent Advances to Personalize Treatment

In-Person + Virtual Event

Unlocking the Future of Glioma Care: Integrating Recent Advances to Personalize Treatment

November 21, 2025

Patient, Provider, and Caregiver Connection™: Pediatric Myasthenia Gravis—Current Treatment and Emerging Concepts

Patient, Provider, and Caregiver Connection™: Pediatric Myasthenia Gravis—Current Treatment and Emerging Concepts

John F. Brandsema, MD; Abigail N. Schwaede, MD; Samuel J. Mackenzie, MD, PhD

Mind Moments™: Optimizing Management for Patients with Generalized Myasthenia Gravis

Mind Moments™: Optimizing Management for Patients with Generalized Myasthenia Gravis

James F. Howard Jr, MD

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

Case-based Simulation

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

Nicholas Doher, DO; Babak Tousi, MD

Cases and Conversations™: Navigating the Complexities of Managing Myasthenia Gravis in Pediatric and Pregnant Patient Populations

Cases and Conversations™: Navigating the Complexities of Managing Myasthenia Gravis in Pediatric and Pregnant Patient Populations

John Brandsema, MD; Neelam Goyal, MD

Identifying and Treating CIDP in the Modern Era

Identifying and Treating CIDP in the Modern Era

Jeffrey A. Allen, MD; Karissa L. Gable, MD

Cases and Conversations™: Little Voices, Big Challenges – Comprehensive Care for Pediatric Spinal Muscular Atrophy

Cases and Conversations™: Little Voices, Big Challenges – Comprehensive Care for Pediatric Spinal Muscular Atrophy

John Brandsema, MD; Carla D. Zingariello, DO

A Breath of Strength: Managing Cancer Associated LEMS and Lung Cancer as One

A Breath of Strength: Managing Cancer Associated LEMS and Lung Cancer as One

Estelamari Rodriguez, MD, MPH; Millie Das, MD; Ruham Nasany, MD

Striking the Right Nerve: Managing Cancer Associated LEMS in Lung Cancer Patients

Striking the Right Nerve: Managing Cancer Associated LEMS in Lung Cancer Patients

Anne Chiang, MD, PhD; J. Douglas Miles, MD, PhD, FAAN; Suma Satti, MD

Patient, Provider, and Caregiver Connection: Improving Diagnosis and Care for Adolescent Myasthenia Gravis Patients – A New Frontier

Patient, Provider, and Caregiver Connection: Improving Diagnosis and Care for Adolescent Myasthenia Gravis Patients – A New Frontier

Abigail N. Schwaede, MD; Emmanuelle (Noelle) Tiongson, MD

A New Era in NMOSD Treatment: Optimizing Therapeutic Transitions and Reducing Patient Burden

A New Era in NMOSD Treatment: Optimizing Therapeutic Transitions and Reducing Patient Burden

Shamik Bhattacharyya, MD, MS, FAAN; Mirla Avila, MD; Dean Wingerchuk, MD

PER Podcast™: Maximizing the Multidisciplinary Care Outcomes of Patients with Amyotrophic Lateral Sclerosis (ALS)

PER Podcast™: Maximizing the Multidisciplinary Care Outcomes of Patients with Amyotrophic Lateral Sclerosis (ALS)

Richard Bedlack, MD, PhD

PER Podcast™: Best Strategies for Approaching the Diagnosis of Amyotrophic Lateral Sclerosis (ALS)

PER Podcast™: Best Strategies for Approaching the Diagnosis of Amyotrophic Lateral Sclerosis (ALS)

Terry Heiman-Patterson, MD

PER Postgame™: Updates from ANNA in the Management of IgA Nephropathy

PER Postgame™: Updates from ANNA in the Management of IgA Nephropathy

Gerald Bernard Appel, MD; Ellie Kelepouris, MD, FACP, FAHA

Patient, Provider, and Caregiver Connection: Turning a New Leaf in Acute Pain Management – How Recent Advancements Impact the Treatment Paradigm

Patient, Provider, and Caregiver Connection: Turning a New Leaf in Acute Pain Management – How Recent Advancements Impact the Treatment Paradigm

Jeffrey Gudin, MD; Jeffrey Bettinger, PharmD

Shining a Light on an Ultra-Rare Disease – A Closer Look at Thymidine Kinase 2 Deficiency (TK2d)

Shining a Light on an Ultra-Rare Disease – A Closer Look at Thymidine Kinase 2 Deficiency (TK2d)

Zarazuela Zolkipli-Cunningham, MBChB, MRCP; Mary Kay Koenig, MD; Perry Shieh, MD, PhD, FAAN, FANA

Identifying and Treating Generalized Myasthenia Gravis in the Modern Era

Identifying and Treating Generalized Myasthenia Gravis in the Modern Era

James F. Howard Jr, MD, FAAN

Addressing Unmet Needs for Patients With Spinal Muscular Atrophy—Understanding Patient Challenges and Management Approaches

Addressing Unmet Needs for Patients With Spinal Muscular Atrophy—Understanding Patient Challenges and Management Approaches

Basil T. Darras, MD

Rewiring Recovery: Evidence-Based Approaches to Managing Chronic Inflammatory Demyelinating Polyneuropathy

Rewiring Recovery: Evidence-Based Approaches to Managing Chronic Inflammatory Demyelinating Polyneuropathy

Karissa Gable, MD

Expert Illustrations & Commentaries™: Visualizing the Role of Dystrophin Dysregulation as a Therapeutic Target in Duchenne Muscular Dystrophy and MD STARnet

Expert Illustrations & Commentaries™: Visualizing the Role of Dystrophin Dysregulation as a Therapeutic Target in Duchenne Muscular Dystrophy and MD STARnet

Anne M. Connolly, MD, FAAN; Amy Moore, PhD

Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights

Cladribine More Effective Than S1P Receptor Modulators in Treating Relapsing-Remitting MS, Study Shows

NeurologyLive® Brain Games: November 16, 2025

Using Machine Learning for Risk Prediction in Multiple Sclerosis Following DMT Discontinuation: Marisa McGinley, DO

FDA Adds Boxed Warning, Narrows Indication for DMD Gene Therapy

BBP-418 Success in LGMD, Alixorexton Improves Narcolepsy Symptoms, Fenebrutinib Meets Phase 3 End Points

© 2025 MJH Life Sciences^®

All rights reserved.